Allison Park, PA, United States of America

Neil Hukriede

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Neil Hukriede

Introduction: Neil Hukriede is an accomplished inventor based in Allison Park, Pennsylvania, known for his significant contributions to the field of biomedical research. With a total of four patents to his name, Hukriede has focused his work on groundbreaking innovations that aim to improve kidney health and recovery from acute kidney injuries.

Latest Patents: Among Hukriede's latest patents is the development of a class of HDAC (histone deacetylase) inhibitors that expands the renal progenitor cells population and enhances the rate of recovery from acute kidney injury. The patents detail compounds and compositions that effectively inhibit histone deacetylase activity, thus promoting the expansion of renal progenitor cell populations and improving kidney functionality in damaged kidneys. Additionally, methods of utilizing these compounds and compositions for therapeutic applications are also outlined in his work.

Career Highlights: Neil Hukriede’s career is marked by his dedication to advancing medical research. He is a key member of the University of Pittsburgh - of the Commonwealth System of Higher Education, where he continues to explore innovative solutions for kidney-related health challenges. His research has not only led to patents but also contributes to the growing body of knowledge in renal medicine.

Collaborations: In his journey, Hukriede has collaborated with notable colleagues such as Billy W Day and Lee A McDermott. These partnerships have played a crucial role in the advancement of his research and the achievement of his innovative patents, showcasing the importance of teamwork in scientific exploration.

Conclusion: Neil Hukriede's innovative work in the field of kidney health represents a significant advancement for biomedical research. With his extensive patent portfolio and collaborative efforts, Hukriede continues to pave the way for new therapies that hold the potential to transform the treatment of acute kidney injuries and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…